Medicare Enrolled
Dr. Jonathan Bender, M.D.
Hematology & Oncology · Fayetteville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bender from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bender?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bender
Dr. Jonathan Bender is a hematology & oncology specialist in Fayetteville, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bender performed 128,794 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bender received a total of $4,278 from 51 pharmaceutical and/or device companies across 197 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bender is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in GA
$4,278 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗128,794
Medicare services
Top 5% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 34,200 | $43 | $110 |
| Denosumab injection (Prolia/Xgeva) | 18,420 | $18 | $44 |
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
18,120 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
15,200 | $2 | $10 |
| Paclitaxel chemotherapy injection | 10,026 | $0 | $0 |
| Iron infusion (Monoferric) | 9,700 | $16 | $65 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,150 | $35 | $110 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
3,020 | $35 | $180 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,541 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,470 | $8 | $27 |
| Injection, fulvestrant, 25 mg | 1,420 | $8 | $80 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 914 | $3 | $10 |
| Anti-nausea injection (Aloxi/palonosetron) | 890 | $1 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
755 | $65 | $168 |
| Injection, leucovorin calcium, per 50 mg | 721 | $3 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
701 | $102 | $525 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
553 | $2 | $5 |
| Injection, granisetron hydrochloride, 100 mcg | 550 | $0 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
544 | $11 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $98 | $260 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
420 | $71 | $450 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
417 | $22 | $118 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
370 | $12 | $82 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
226 | $2 | $10 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
207 | $51 | $250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
196 | $50 | $235 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
184 | $1 | $2 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
176 | $27 | $126 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
140 | $16 | $90 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
138 | $22 | $131 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
90 | $44 | $218 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
90 | $1 | $3 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $35 | $122 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 66 | $347 | $1,325 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
61 | $3 | $15 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
61 | $31 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
61 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 60 | $173 | $544 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
60 | $180 | $550 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
55 | $72 | $90 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
47 | $79 | $382 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
37 | $15 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $134 | $376 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
31 | $9 | $97 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
30 | $25 | $194 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
30 | $19 | $96 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
30 | $2 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $131 | $429 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $78 | $304 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $61 | $172 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
12.9% high complexity
84.6% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,278
Total received (2018-2024)
Avg $611/year across 7 years
Top 46% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
197
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$805
2023
$1,218
2022
$520
2021
$67
2020
$221
2019
$833
2018
$615
Payments by company (2024)
ABBVIE INC.
$225
AstraZeneca Pharmaceuticals LP
$121
PFIZER INC.
$73
Daiichi Sankyo Inc.
$55
Stemline Therapeutics Inc.
$50
Genentech USA, Inc.
$49
Merck Sharp & Dohme LLC
$28
TerSera Therapeutics LLC
$28
SpringWorks Therapeutics, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$21
Alexion Pharmaceuticals, Inc.
$19
Mirati Therapeutics, Inc.
$17
Janssen Biotech, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$16
CSL Behring
$16
Bayer Healthcare Pharmaceuticals Inc.
$14
Dendreon Pharmaceuticals LLC
$14
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
McKesson Specialty Care Distribution, LLC
$403
Janssen Biotech, Inc.
$317
Novartis Pharmaceuticals Corporation
$282
Gilead Sciences, Inc.
$243
ABBVIE INC.
$225
Regeneron Healthcare Solutions, Inc.
$199
Merck Sharp & Dohme LLC
$189
Astellas Pharma US Inc
$162
Daiichi Sankyo Inc.
$155
AstraZeneca Pharmaceuticals LP
$147
Merck Sharp & Dohme Corporation
$131
Genentech USA, Inc.
$131
Stemline Therapeutics Inc.
$129
Amgen Inc.
$123
E.R. Squibb & Sons, L.L.C.
$121
PFIZER INC.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$110
Rigel Pharmaceuticals, Inc.
$91
Seagen Inc.
$74
Pharmacyclics LLC, an AbbVie Company
$71
Array BioPharma Inc.
$65
Foundation Medicine, Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$57
AbbVie Inc.
$51
Janssen Pharmaceuticals, Inc
$48
Mirati Therapeutics, Inc.
$46
Celgene Corporation
$38
Ipsen Biopharmaceuticals, Inc
$37
Lexicon Pharmaceuticals, Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$34
Karyopharm Therapeutics Inc.
$33
Alexion Pharmaceuticals, Inc.
$31
TerSera Therapeutics LLC
$28
Lilly USA, LLC
$26
SpringWorks Therapeutics, Inc.
$23
PORTOLA PHARMACEUTICALS, INC.
$20
Puma Biotechnology, Inc.
$19
G1 Therapeutics, Inc.
$19
Epizyme, Inc.,
$19
GENZYME CORPORATION
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Kite Pharma, Inc.
$17
CSL Behring
$16
RECORDATI_RARE_DISEASES_INC.
$16
Advanced Accelerator Applications
$14
Dendreon Pharmaceuticals LLC
$14
AMAG Pharmaceuticals, Inc.
$13
CTI BioPharma Corp.
$13
Octapharma USA, Inc.
$12
Teva Pharmaceuticals USA, Inc.
$12
Exelixis Inc.
$11
Top 3 companies account for 23.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BEVYXXA · BOSULIF · Braftovi · CABOMETYX · COSELA · Columvi · DARZALEX · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · EPKINLY · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Hizentra · IBRANCE · IMBRUVICA · JADENU · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUPRON DEPOT · LYNPARZA · Lutathera · MEKINIST · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PROMACTA · PROVENGE · Padcev · Perjeta · Revlimid · Rezlidhia · SANDOSTATIN · SANDOSTATIN LAR · SCEMBLIX · SUTENT · SYLVANT · Soliris · Stivarga · TAGRISSO · TAZVERIK · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Vonjo · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Yescarta · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
102
County median income
$108,986
Nearest hospital to ZIP centroid (approximate)
PIEDMONT FAYETTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bender is a mixed practice specialist, with above-average Medicare volume (top 5% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bender experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Bender performed 34,200 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bender receive payments from pharmaceutical companies?
Yes. Dr. Bender received a total of $4,278 from 51 companies across 197 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bender's costs compare to other hematology & oncology specialists in Fayetteville?
Dr. Bender's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bender) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fayetteville
Browse hematology & oncology specialists in Fayetteville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
McKesson Specialty Care Distribution, LLC Payments to Doctors
See all physicians who received payments from McKesson Specialty Care Distribution, LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology